“…Careful readings of the 22 full manuscripts further reduced the field to nine studies that met all inclusion criteria. [33][34][35][36][37][38][39][40][41][42] Of these studies, six included adolescent survivors, two addressed young adult survivors only, and one included both young adult and adolescent survivors. Interventions were heterogeneous across study design (nonrandomized, noncontrolled versus randomized, controlled trial), sample sizes (range =10-251), ages (range =3-39 years of age), diagnoses (acute lymphoblastic leukemia [ALL], brain tumor, mixed diagnoses), and points of intervention (on-treatment, immediate postcompletion of treatment, long-term survivorship).…”